Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

C-Rad announces confirmation by the Stockholm Patent and Market court of its entitlement under dispute over Beamocular patent.

Document Cited in Related
Vincent

NORDIC BUSINESS REPORT-July 29, 2019-C-Rad announces confirmation by the Stockholm Patent and Market court of its entitlement under dispute over Beamocular patent

(C)2019 M2 COMMUNICATIONS http://www.m2.com

C-Rad AB (STO:CRADB), a developer of innovative solutions for use in advanced radiation therapy, announced on Friday that the Stockholm Patent and Market court has confirmed C-Rad's entitlement to the patent application 'Ionizing radiation detecting device' in its verdict published on 26 July 2019.

C-Rad had filed a patent entitlement lawsuit in May 2017 against the company Beamocular AB.

Reportedly, a patent application for an invention was filed by Beamocular on 2 March 2015, followed by a PCT patent application on 2 March 2016. The founder and CEO of Beamocular, Kristofer Maad was previously employed as the CEO of C-Rad Imaging AB, a subsidiary of C-Rad, until September 2014.

C-Rad Imaging is focused on the development of a portal imaging and dosimetry device.

The disputed invention is related to the research and development for C-Rad's imaging detector for which C-Rad Imaging has filed its own earlier patent application in 2013, which now is a granted US patent. The detector...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT